Jump directly to the page contents

Cannabis – but safe

The Federal Government plans to enable the controlled dispensing of cannabis to adults in Germany. But how can you ensure young people and health are protected and what rules should apply in the future regarding the selling and cultivating of cannabis, and to road safety? As part of the ‘Cannabis – but safe’ consultation process, these questions will be discussed with experts during the course of several hearings.

FAQ – Frequently Asked Questions

Will cannabis be legalised in Germany?

The Coalition partners agreed on enabling the “controlled dispensing of cannabis for recreational purposes to adults through licenced stores”. Within a clearly defined legal framework, the selling, buying and possession of cannabis shall be permitted. The primary goal and guiding principle of the legislative procedure will be to ensure consumers’ health is protected to the highest possible degree and that children and young people are protected.

When will the controlled dispensing of cannabis actually commence in Germany?

Since the implementation of this aspect of the Coalition Agreement is a complex project, it needs to be carefully prepared. Therefore, the key issues regarding youth, health and consumer protection, cultivation, trade, taxation, etc. will be discussed in the summer of 2022 in the context of a structured consultation process headed by the Commissioner of the Federal Government for Drug and Addiction Policy. The aim is to submit a draft bill as early as this year.

What is the consultation process about?

The consultation process aims to pool the expertise required to implement the project and complement it with the experiences of other countries. In addition, it is important to create a space where concerns and objections, too, can be openly addressed and discussed. To this end, the key questions around controlled dispensing will be closely examined by both experts and civil society stakeholders. The consultation process, currently envisaged to comprise five hearings, will be headed by the Drug and Addiction Commissioner of the Federal Government, Burkhard Blienert, and conducted in coordination with the Federal Ministry of Health. The various federal ministries, which will be involved in drafting the bill, will also take part in the events of the consultation process.

When does the consultation process begin?

From mid-June 2022, experts and civil society stakeholders will meet on several days to discuss relevant issues regarding the implementation of the controlled dispensing of cannabis. The exact dates are published on this site.

Will the consultation process be public? Can I take part?

The aim of the consultation process is to involve the broadest possible range of relevant stakeholders in a structured manner, giving each group an equal opportunity to adequately express their point of view. This requires limiting the number of participants. The selection of participants is determined by the Drug and Addiction Commissioner in coordination with the Federal Ministry of Health as well as the other federal ministries. It is not possible to apply for participation. However, we will ensure transparency by publishing the topics, participants and – if possible – the key statements of those involved on the Drug and Addiction Commissioner’s website. In addition, one of the events will be streamed.

Are there licences already available for the commercial cultivation and distribution of cannabis?

No. The precise production and distribution requirements are currently being worked out and will be defined later on in the legislative process.

Will personal cultivation be allowed? Will criminal convictions due to possession of cannabis be stricken from the record? What safety limits will apply to road traffic? From what age will cannabis be available for purchase?

At this point in time, these and similar questions are impossible to answer. These topics will be clarified later on in the legislative process.

Overview of hearings

I (14 June 2022): Health and consumer protection

II (15 June 2022): Youth protection and prevention

III (28 June 2022): Supply chains, economic and ecological issues

IV (29 June 2022): Criminal liability, inspection measures and licencing

V (30 June 2022): International Expert Hearing – conference on international experience

I Health and consumer protection

Date: 14 June 2022, 9.00-16.00

Invited participants:

Arbeitsgemeinschaft der obersten Landesgesundheitsbehörden (AOLG)
Arbeitsgruppe Sucht der Gesundheitsministerkonferenz (GMK)
Berufsverband der Kinder- und Jugendärzte (BVKJ)
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)
Bundesarbeitsgemeinschaft Kinder- und Jugendschutz e.V. (BAJ)
Bundesärztekammer (BÄK)
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Bundesinstitut für Risikobewertung (BfR)
Bundespsychotherapeutenkammer (BPtK)
Bundesverband für akzeptierende Drogenarbeit und humane Drogenpolitik (akzept e.V.)
Bundesvereinigung der kommunalen Spitzenverbände
Bundesvereinigung Deutscher Apothekerverbände e.V. (ABDA)
Bundeszentrale für gesundheitliche Aufklärung (BZgA)
Deutsche Aidshilfe (DAH)
Deutsche Beobachtungsstelle für Drogen und Drogensucht (DBDD)
Deutsche Gesellschaft für Kinder- und Jugendmedizin e. V. (DGKJ)
Deutsche Gesellschaft für Prävention und Gesundheitsförderung (DGPG)
Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e. V (DGPPN)
Deutsche Gesellschaft für Suchtforschung und Suchttherapie e. V. (DG-Sucht)
Deutsche Gesellschaft für Suchtmedizin e.V. (DGS)
Deutsche Hauptstelle für Suchtfragen e.V. (DHS)
Deutscher Hanfverband (DHV)
Deutsches Zentrum für Suchtfragen des Kindes- und Jugendalters (DZSKJ)
IFT-Nord
Institut für Therapieforschung (IFT)
Jugend- und Familienministerkonferenz der Länder (JFMK)
Landesstellen für Suchtfragen
Nationaler Aktionsplan Gesundheitskompetenz (Hertie School)
Universitätsmedizin Göttingen (UMG)
Verbraucherzentrale Bundesverband (vzbv)

II Youth protection and prevention

Date: 15 June 2022, 9.00-16.00

Invited participants:

Arbeitsgemeinschaft der obersten Landesgesundheitsbehörden (AOLG)
Arbeitsgruppe Sucht der Gesundheitsministerkonferenz (GMK)
Berufsverband der Kinder- und Jugendärzte (BVKJ)
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL)
Bundesarbeitsgemeinschaft Kinder- und Jugendschutz e.V. (BAJ)
Bundesärztekammer (BÄK)
Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM)
Bundesinstitut für Risikobewertung (BfR)
Bundespsychotherapeutenkammer (BPtK)
Bundesverband für akzeptierende Drogenarbeit und humane Drogenpolitik (akzept e.V.)
Bundesvereinigung der kommunalen Spitzenverbände
Bundesvereinigung Deutscher Apothekerverbände e.V. (ABDA)
Bundeszentrale für gesundheitliche Aufklärung (BZgA)
Deutsche Aidshilfe (DAH)
Deutsche Beobachtungsstelle für Drogen und Drogensucht (DBDD)
Deutsche Gesellschaft für Kinder- und Jugendmedizin e. V. (DGKJ)
Deutsche Gesellschaft für Prävention und Gesundheitsförderung (DGPG)
Deutsche Gesellschaft für Psychiatrie und Psychotherapie, Psychosomatik und Nervenheilkunde e. V (DGPPN)
Deutsche Gesellschaft für Suchtforschung und Suchttherapie e. V. (DG-Sucht)
Deutsche Gesellschaft für Suchtmedizin e.V. (DGS)
Deutsche Hauptstelle für Suchtfragen e.V. (DHS)
Deutscher Hanfverband (DHV)
Deutsches Zentrum für Suchtfragen des Kindes- und Jugendalters (DZSKJ)
IFT-Nord
Institut für Therapieforschung (IFT)
Jugend- und Familienministerkonferenz der Länder (JFMK)
Landesstellen für Suchtfragen
Nationaler Aktionsplan Gesundheitskompetenz (Hertie School)
Universitätsmedizin Göttingen (UMG)
Verbraucherzentrale Bundesverband (vzbv)

III Supply chains, economic and ecological issues

Date: 28 June 2022, 9.00-16.00

 

IV Criminal liability, inspection measures and licencing

Date: 29 June 2022, 9.00-16.00

 

V International Expert Hearing – conference on international experience

Date: 30.06.2022, 9.00-16.00

This hearing will we available to watch as a video stream.